menu search

Sanofi: 3 reasons for a buy

The French Pharma company is moving on an immunology franchise. Dupixent is the internal cash cow to dr...

September 21, 2023, 9:26 am

Checkpoint therapeutics to participate in the cantor global healthcare conference

WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage ...

September 21, 2023, 8:30 am

Affimed to present at the cantor global healthcare conference 2023

MANNHEIM, Germany, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage ...

September 21, 2023, 6:30 am

Frontier portfolio company signs collaboration deal with merck

Frontier IP Group PLC (AIM:FIPP), a firm specialising in the commercialisation of intellectual property, announced in an RNS today that its portfolio ...

September 21, 2023, 4:01 am

Exscientia stock surges on merck kgaa partnership

Exscientia PLC shares climbed as much as 30% in pre-market trading on Wednesday after the precision-medicine company announced a new, multi-year coll...

September 20, 2023, 9:13 am

Exscientia's stock rockets toward a record gain after ai-driven drug discovery collaboration with germany's merck kgaa

The U.S.-listed shares of Exscientia PLC EXAI soared 28.5% toward a record one-day gain, and enough to pace all premarket gainers on major U.S. exchan...

September 20, 2023, 7:50 am

Poolbeg pharma shores up protection around its ip

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), the clinical-stage biopharmaceutical firm, recently received a notice of allowance from the Japanese Paten...

September 20, 2023, 3:31 am

Poolbeg pharma: third party withdraws patent opposition

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said that an unnamed 'third party' has agreed to withdraw its opposition to one of the company's European ...

September 19, 2023, 2:49 am

Estrella immunopharma nears completion of spac listing

Estrella immunopharma is nearing completion of its New York listing using a SPAC backed by China's UP F...

September 19, 2023, 1:30 am

Harpoon therapeutics announces first patients with small cell lung cancer dosed in hpn328 combination cohort

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage ...

September 15, 2023, 11:15 am

Nvidia and amgen back ai drug developer generate:biomedicines' $273m financing

Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical and clinical development across oncology, ...

September 14, 2023, 11:29 am

Genelux corporation reports inducement grants under nasdaq listing rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage ...

September 14, 2023, 11:00 am

Cancervax ceo ryan davies discusses the company’s growing pipeline of cancer treatments

The Company’s development pipeline now includes three projects with UCLA LEHI, Utah, Sept. 14, 2023 (GLOBE NEWSWIRE) — CancerVAX, Inc., a pre-clin...

September 14, 2023, 7:01 am

Sensei biotherapeutics to present new preclinical data supporting mechanism of action, pharmacokinetic profile and safety characteristics for sns-101, a conditionally active vista-blocking antibody, a

BOSTON, Sept. 13, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immu...

September 13, 2023, 11:30 am

Moderna (mrna), immatics ink deal to develop new cancer therapies

The deal will combine Moderna (MRNA) and Immatics' (IMTX) proprietary platforms to develop innovative immuno...

September 12, 2023, 1:35 pm

Why shares of moonlake immunotherapeutics are rising tuesday

MoonLake is a clinical-stage biotech that focuses on inflammatory diseases. Its lead therapy, sonelokimab, is being tested against several conditions....

September 12, 2023, 11:40 am

Zyversa therapeutics announces research published in frontiers in immunology reinforcing ic 100’s rationale for inhibiting multiple inflammasomes to control inflammation in various inflammatory diseas

Activation of multiple inflammasome pathways contributes to pathological inflammation in neurodegenerative (“CNS”) diseases, such as amyotrophic l...

September 12, 2023, 10:30 am

Anaptysbio to present at the stifel 2023 immunology and inflammation virtual summit

SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative...

September 12, 2023, 9:15 am


Search within

Pages Search Results: